Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.

Item
http://www.wikidata.org/entity/Q46099469
The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical researchCorrelation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic.Gastric corpus atrophy in gastric cancer screenings: Benefits and drawbacks.Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.Marked decrease in serum pepsinogen II levels resulting from endoscopic resection of a large duodenal tumor.NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreasRationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.Diagnosis of Zollinger-Ellison syndrome: increasingly difficult.Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.Gastric acid hypersecretory states: recent insights and advances.High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury.Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.Accuracy of the GastroPanel test in the detection of atrophic gastritis.Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.Influence of endoscopic submucosal dissection on serum levels of pepsinogens in patients with early gastric cancer.
P2860

Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.

Item
http://www.wikidata.org/entity/Q46099469
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Clinical use of proton-pump in ...... in a random adult population.
@en
Clinical use of proton-pump in ...... in a random adult population.
@nl
type
label
Clinical use of proton-pump in ...... in a random adult population.
@en
Clinical use of proton-pump in ...... in a random adult population.
@nl
prefLabel
Clinical use of proton-pump in ...... in a random adult population.
@en
Clinical use of proton-pump in ...... in a random adult population.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Clinical use of proton-pump in ...... in a random adult population.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698